Millennium Management
ARGS

Millennium Management’s Argos Therapeutics, Inc. ARGS Stock Holding History

Millennium Management’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,002
Closed -$32K – 4338
2017
Q3 		$32K Sell
9,002
-663
-7% -$3.18K ﹤0.01% 3432
2017
Q2 		$70K Buy
+9,665
New +$82.3K ﹤0.01% 3339
2017
Q1 		– Sell
-7,156
Closed -$701K – 4161
2016
Q4 		$701K Buy
7,156
+5,981
+509% +$560K ﹤0.01% 2464
2016
Q3 		$117K Buy
+1,175
New +$123K ﹤0.01% 3102

Other funds holding ARGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Millennium Management's ARGS Position: Q4 2017 in Review

Millennium Management sold out of Argos Therapeutics, Inc. (ARGS) in Q4 2017, closing a stake of 9,002 shares — an estimated $32K sold.

Millennium Management first reported a position in ARGS in Q3 2016 and held it in 4 quarters. The position peaked at $701K in Q4 2016. 28 funds tracked by Wall St. Rank hold ARGS as of Q4 2017.

  • Millennium Management reported no remaining Argos Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Millennium Management sold 9,002 Argos Therapeutics, Inc. shares in Q4 2017, an estimated $32K.
  • Millennium Management first reported a position in Argos Therapeutics, Inc. in Q3 2016 and held it in 4 quarters.
  • Millennium Management's Argos Therapeutics, Inc. position peaked at $701K in Q4 2016.
  • 28 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q4 2017.

Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.